Journal of Cardiovascular Disease Research
INTRAVENOUS LIDOCAINE AND NALBUPHINE IN PAIN MANAGEMENT FOR UPPER EXTREMITY FRACTURE- A CLINICAL TRIAL
Dr. ADUSUMILLI BHAVANA SRI, Dr. Belli Yashaswi, Dr. Abhijith Kanti Dam, Dr. Birendra Kumar, Dr. Dharun Jims D A, Dr. Harihar Jadhav
JCDR. 2024: 3889 -3916
Abstract
Background- Lidocaine is a relatively safe drug in the amide group, which acts as an analgesic, anti-hyperalgesia and anti-inflammatory agent in low doses and is affective in relieving neuralgia, burn and procedural pains. Nalbuphine is a newer opioid drug with antagonism at µ receptors and agonism at κ receptors, with no significant effects on delta receptors.
» PDF